MindBio Therapeutics Corp.
MBIO
CNSX
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 163.92% | -69.91% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 186.99% | 22.45% | |||
Operating Income | -186.99% | 89.67% | |||
Income Before Tax | -725.08% | 82.62% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -725.08% | 82.62% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | 800.00% | -- | |||
Net Income | -705.21% | 82.39% | |||
EBIT | -186.99% | 89.67% | |||
EBITDA | -- | -- | |||
EPS Basic | -800.00% | 84.62% | |||
Normalized Basic EPS | -1,000.00% | 87.50% | |||
EPS Diluted | -800.00% | 84.62% | |||
Normalized Diluted EPS | -1,000.00% | 87.50% | |||
Average Basic Shares Outstanding | 0.88% | -2.21% | |||
Average Diluted Shares Outstanding | 0.88% | -2.21% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |